| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 12/10/2008 | CN101319004A N terminal specific human YWHAE polypeptide and antibody preparation method |
| 12/10/2008 | CN101319003A C terminal specific human YWHAE polypeptide and antibody preparation method |
| 12/10/2008 | CN101319002A N terminal specific human MDC1 polypeptide and antibody preparation method |
| 12/10/2008 | CN101319001A N terminal specific human DBF4B polypeptide and antibody preparation method |
| 12/10/2008 | CN101319000A C terminal specific human TP53I3 polypeptide and antibody preparation method |
| 12/10/2008 | CN101318999A N terminal specific human Eme1 polypeptide and antibody preparation method |
| 12/10/2008 | CN101318998A C terminal specific human Eme1 polypeptide and antibody preparation method |
| 12/10/2008 | CN101318997A C terminal specific human DNA mismatch repair protein MLH1 polypeptide and antibody preparation method |
| 12/10/2008 | CN101318996A C terminal specific human BTRC polypeptide and antibody preparation method |
| 12/10/2008 | CN101318995A Substituted tetrahydro-isoquinoline isoquinolinium compound, preparation method and application thereof |
| 12/10/2008 | CN101318994A Substituted tetrahydro-isoquinoline-3-carboxylic acid compound, preparation method and application thereof |
| 12/10/2008 | CN101318993A Hybridized peptide with 3S-tetrahydrochysene-beta-carboline-3-carboxylic acid as connecting arm, preparation method and application thereof |
| 12/10/2008 | CN101318992A Complete-basic amino acid oligopeptide, copper complex, synthesis method, self-assembly and application thereof |
| 12/10/2008 | CN100441595C Novel peptides that bind to the erythropoietin receptor |
| 12/10/2008 | CN100441594C Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 12/09/2008 | US7462690 form a carboxyl-terminal amide of a desired peptide comprising contacting a substrate polypeptide and a palladium complex, where the palladium complex is a palladium(II) or palladium(IV) complex |
| 12/09/2008 | US7462686 On-growth inhibiting compounds |
| 12/09/2008 | US7462598 Antimicrobial theta defensins, analogs thereof, and methods of use |
| 12/09/2008 | US7462593 Compositions and methods for promoting angiogenesis |
| 12/09/2008 | US7462592 Compositions and methods for polynucleotide delivery |
| 12/09/2008 | US7462486 Monitoring the efficacy of a T Cell Receptor (TCR) Variable peptide for the treatment of autoimmune diseases such as multiple sclerosis, Rheumatoid arthritis, systemic lupus erythematosis, type I diabetes, non-obese diabetes, psoriasis |
| 12/09/2008 | US7462462 Peptide capable of binding to nanographite structures |
| 12/09/2008 | US7462360 for induction of interferon/natural killer cell activity; for treating viral/fungal systemic infections, or oncological diseases |
| 12/09/2008 | CA2202504C Chimeric conformational epitope peptides |
| 12/04/2008 | WO2008147304A1 A novel neuroprotective peptide |
| 12/04/2008 | WO2008146003A1 Vaccine peptide combinations against cat allergy |
| 12/04/2008 | WO2008145998A1 Vaccine peptide combinations against cat allergy |
| 12/04/2008 | WO2008145603A2 Pharmaceutical compositions comprising telomerase, and uses thereof |
| 12/04/2008 | WO2008144919A1 Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues |
| 12/04/2008 | WO2008125800A3 Mmp activated vascular disrupting agents |
| 12/04/2008 | WO2008086813A3 Peptides derived from proteins of the insulin super-family |
| 12/04/2008 | WO2007117588A3 Soluble virus-specific t-cell receptor compositions |
| 12/04/2008 | WO2007114959A3 Altered peptide ligands of gad65 |
| 12/04/2008 | WO2006031727A3 Peptides for treatment of autoimmune diseases |
| 12/04/2008 | US20080300220 Linkable Lewis X Analogs |
| 12/04/2008 | US20080300207 Protein production |
| 12/04/2008 | US20080300203 Stable Quantitation and Detection of Immune Response Levels with Non-Zero Background Peptides |
| 12/04/2008 | US20080300193 Composition and Method for the Treatment of Diseases Affected by a Peptide Receptor |
| 12/04/2008 | US20080300191 Cbz-Leu-Gln-fluoromethyl ketone; 4-(Cbz-Val-Leu-amido)-6-fluoro-5-oxo-hexanoic acid dimethylamide; 4-(Cbz-Leu-amido)-6-Fluoro-5-oxo-hexanoic acid methylamide; 4-(Cbz-Ile-amido)-6-fluoro-5-oxo-hexanoic acid methylamide; 4-(Cbz-Val-amido)-6-fluoro-5-oxo-hexanoic acid methylamide |
| 12/04/2008 | US20080300190 Human proIslet Peptides are used either alone or in combination with other pharmaceuticals in the treatment of type 1 and type 2 diabetes and other pathologies related to aberrant glucose, carbohydrate, and/or lipid metabolism, insulin resistance, overweight, obesity, polycystic ovarian syndrome, eating |
| 12/04/2008 | US20080300180 Growth Hormone Secretagogue Receptor 1A Ligands |
| 12/04/2008 | US20080300177 Provided are lactam-cyclized peptide CXCR4 antagonists (g-coupled protein receptor inhibitors) and a ligand SDF-1 (stromal cell-derived factor-1) useful in the in the treatment of cancers, rheumatoid arthritis, pulmonary fibrosis, and HIV infection |
| 12/04/2008 | US20080300175 Glycopegylated erythropoietin |
| 12/04/2008 | US20080300167 Patched genes and uses related thereto |
| 12/04/2008 | US20080299677 New assays for preimplantation factor and preimplantation factor peptides |
| 12/04/2008 | US20080299596 Substrates and assays for beta-secretase activity |
| 12/04/2008 | US20080299592 Red-Shifted Luciferase |
| 12/04/2008 | US20080299580 Targeted integration into the PPP1R12C locus |
| 12/04/2008 | US20080299180 Peptides based on the sequence of human lactoferrin and their use |
| 12/04/2008 | US20080299139 Mammalian cytokines; related reagents and methods |
| 12/04/2008 | US20080299127 Protective staphylococcus aureus vaccine based on cell wall-associated proteins |
| 12/04/2008 | US20080299108 Peptides for Diagnostic and Therapeutic Methods for Celiac Sprue |
| 12/04/2008 | US20080299078 Tumor associated amino acids and uses therefor |
| 12/04/2008 | US20080299040 Diagnosis and therapy of cancer and noncancerous diseases; complexes with radioactive material |
| 12/04/2008 | US20080299039 Aprotinin Polypeptides for Transporting a Compound Across the Blood-Brain Barrier |
| 12/04/2008 | CA2689260A1 Vaccine peptide combinations against cat allergy |
| 12/04/2008 | CA2688344A1 Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues |
| 12/03/2008 | EP1997827A1 Compounds analogous to growth hormone peptide secretagogues and preparations containing them |
| 12/03/2008 | EP1997826A2 Synthetic ligands for immunoglobulins and pharmaceutical compositions containing them |
| 12/03/2008 | EP1996633A2 Molecular imprintings for recognition in aqueous media, methods for preparing same and uses thereof |
| 12/03/2008 | EP1996612A1 Compositions for treatment of cancer |
| 12/03/2008 | EP1996608A1 Cyclopeptide with anti-cancer activity derived from collagen type iv |
| 12/03/2008 | EP1996607A2 Lymphatic zip codes in tumors and pre-malignant lesions |
| 12/03/2008 | EP1996235A1 Polypeptides, pharmaceutical compositions and methods for the prevention and the therapeutic treatment of inflammatory disorders |
| 12/03/2008 | EP1204677B1 Cyclohexapeptide compounds, process for their production and their use as a pharmaceutical |
| 12/03/2008 | CN101316859A Aryiialkyl and heteroarylalkyl derivatives of cyclosporine A for the treatment and prevention of viral infection |
| 12/03/2008 | CN101315367A Preparation of carcinoma antigen 125 EUSA detection reagent kit |
| 12/03/2008 | CN101314614A Polypeptide combinative with PKR kinase structure field specificity and uses thereof |
| 12/03/2008 | CN101314613A Solid phase synthesis method for atosiban |
| 12/03/2008 | CN100438906C The use of copolymer 1 and related peptides and polypeptides and T cell treated therewith for neuroprotective therapy |
| 12/02/2008 | US7459533 Interleukin-10 homolog for use as a therapeutic tool in treatment and prevention of inflammatory, autoimmue and cell proliferative disorders |
| 12/02/2008 | US7459522 Peptide dimers as agonists of the erythropoietin (EPO) receptor, and associated methods of synthesis and use |
| 12/02/2008 | US7459424 Peptide inhibitors of protein kinase C γ for pain management |
| 12/02/2008 | US7459275 Sequencing of surface immobilized polymers utilizing microfluorescence detection |
| 12/02/2008 | CA2409771C Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes |
| 12/02/2008 | CA2303395C Treatment of obesity |
| 12/02/2008 | CA2265484C Tumor homing molecules, conjugates derived therefrom, and methods of using same |
| 11/27/2008 | WO2008143947A1 Farnesylamine derivatives and methods of use |
| 11/27/2008 | WO2008142319A2 Peptide analogues of melanocortin receptors |
| 11/27/2008 | WO2008030988A3 Selectively targeted antimicrobial peptides and the use thereof |
| 11/27/2008 | US20080293917 Peptide Purification By Means Of Metal Ion Affinity Chromatography |
| 11/27/2008 | US20080293916 Hla-Binding Peptide, and Dna Fragment and Recombinant Vector Coding for Said Hla-Binding Peptide |
| 11/27/2008 | US20080293641 Biologically active peptides |
| 11/27/2008 | US20080293640 Polypeptide inhibitors of HSP27 kinase and uses therefor |
| 11/27/2008 | US20080293149 very early marker of fertilization and embryo viability; binds to anti-CD2 antibody; Infertility |
| 11/27/2008 | US20080292652 Virus-Like Particles Comprising a Fusion Protein of the Coat Protein of Ap205 and an Antigenic Polypeptide |
| 11/27/2008 | US20080292641 Antigenic GM-CSF peptides and antibodies to GM-CSF |
| 11/27/2008 | US20080292639 Humanized Anti-Amyloid Antibody |
| 11/27/2008 | US20080292623 Mammalian cell membrane proteins; related reagents |
| 11/27/2008 | US20080292617 Antibody against a peptide derived from human mutant lamin a protein and uses thereof |
| 11/27/2008 | US20080292576 Method for identifying hair conditioner-resistant hair-binding peptides and hair benefit agents therefrom |
| 11/27/2008 | US20080292548 Compounds and methods for 18f labeled agents |
| 11/27/2008 | CA2676028A1 Methods of determining lethality of pathogens and malignancies involving replikin peak genes |
| 11/26/2008 | EP1994942A1 Pharmaceutical compositions comprising telomerase, and uses thereof |
| 11/26/2008 | EP1994152A1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 11/26/2008 | EP1994046A1 Presentation of recognition motifs by a multivalent matrix grafted onto a solid support |
| 11/26/2008 | EP1588173B1 Affinity fishing for ligands and proteins receptors |
| 11/26/2008 | EP1543142B1 Production method for iturin a and its homologues |
| 11/26/2008 | EP1419173B1 Peptides that bind to atherosclerotic lesions |
| 11/26/2008 | EP1396539B1 Human-type anti-blood coagulation factor viii antibody |